In marked contrast to patients with C-terminal processing-resistant p100 variants, none of the individuals with p52/p100 haploinsufficiency or p52GOF variants studied to date has developed pituitary defects or ectodermal dysplasia. This evidence concerns the gene NFKB2 and hypophysitis.